These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease. Garland JS; Holden RM; Groome PA; Lam M; Nolan RL; Morton AR; Pickett W Am J Kidney Dis; 2008 Nov; 52(5):849-58. PubMed ID: 18562059 [TBL] [Abstract][Full Text] [Related]
6. The treatment of coronary artery disease in patients with chronic kidney disease. Edwards NC; Steeds RP; Ferro CJ; Townend JN QJM; 2006 Nov; 99(11):723-36. PubMed ID: 17040978 [TBL] [Abstract][Full Text] [Related]
7. Percutaneous coronary interventions in the high-risk renal patient: strategies for renal protection and vascular protection. McCullough PA; Berman AD Cardiol Clin; 2005 Aug; 23(3):299-310. PubMed ID: 16084279 [TBL] [Abstract][Full Text] [Related]
8. Statins and cardiovascular risk reduction in patients with chronic kidney disease and end-stage renal failure. Baber U; Toto RD; de Lemos JA Am Heart J; 2007 Apr; 153(4):471-7. PubMed ID: 17383281 [TBL] [Abstract][Full Text] [Related]
9. Evidence of systemic inflammation and estimation of coronary artery disease risk: a population perspective. Wilson PW Am J Med; 2008 Oct; 121(10 Suppl 1):S15-20. PubMed ID: 18926165 [TBL] [Abstract][Full Text] [Related]
10. Knowledge and awareness of peripheral vascular disease are poor among women at risk for cardiovascular disease. Bush RL; Kallen MA; Liles DR; Bates JT; Petersen LA J Surg Res; 2008 Apr; 145(2):313-9. PubMed ID: 18222479 [TBL] [Abstract][Full Text] [Related]
11. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment]. Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737 [TBL] [Abstract][Full Text] [Related]
12. Reducing the burden of cardiovascular calcification in patients with chronic kidney disease. Qunibi WY J Am Soc Nephrol; 2005 Nov; 16 Suppl 2():S95-102. PubMed ID: 16251249 [TBL] [Abstract][Full Text] [Related]
13. Management of coronary artery disease in patients with chronic kidney disease. Coats WC; Baig SZ; Alpert MA; Aggarwal K Adv Perit Dial; 2009; 25():125-8. PubMed ID: 19886333 [TBL] [Abstract][Full Text] [Related]
14. Arterial calcification and stiffness in chronic kidney disease. Kerr PG; Guerin AP Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):683-7. PubMed ID: 17581230 [TBL] [Abstract][Full Text] [Related]
16. Optimal medical management of peripheral arterial disease. Rice TW; Lumsden AB Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725 [TBL] [Abstract][Full Text] [Related]
17. Valvular calcification and its relationship to atherosclerosis in chronic kidney disease. Leskinen Y; Paana T; Saha H; Groundstroem K; Lehtimäki T; Kilpinen S; Huhtala H; Airaksinen J J Heart Valve Dis; 2009 Jul; 18(4):429-38. PubMed ID: 19852148 [TBL] [Abstract][Full Text] [Related]
18. Increased targeting of cardiovascular risk factors in patients with chronic kidney disease does not improve atheroma burden or cardiovascular function. Isbel NM; Haluska B; Johnson DW; Beller E; Hawley C; Marwick TH Am Heart J; 2006 Mar; 151(3):745-53. PubMed ID: 16504645 [TBL] [Abstract][Full Text] [Related]
19. The burden of peripheral artery disease and the role of antiplatelet therapy. Aronow H; Hiatt WR Postgrad Med; 2009 Jul; 121(4):123-35. PubMed ID: 19641278 [TBL] [Abstract][Full Text] [Related]
20. Peripheral arterial disease in patients with stages IV and V chronic renal failure. Guerrero A; Montes R; Muñoz-Terol J; Gil-Peralta A; Toro J; Naranjo M; González-Pérez P; Martín-Herrera C; Ruiz-Fernández A Nephrol Dial Transplant; 2006 Dec; 21(12):3525-31. PubMed ID: 16940320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]